Clinical Distribution Characteristics and Antimicrobial Resistance Trends of Klebsiella pneumoniae in a Chinese Tertiary Hospital (2021-2025).

IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES
Infection and Drug Resistance Pub Date : 2026-10-04 eCollection Date: 2026-01-01 DOI:10.2147/IDR.S633846
Kang Liu, Zhi Zheng, Lili Liu, Wanjun Wang, Xiaoyue Li
{"title":"Clinical Distribution Characteristics and Antimicrobial Resistance Trends of <i>Klebsiella pneumoniae</i> in a Chinese Tertiary Hospital (2021-2025).","authors":"Kang Liu, Zhi Zheng, Lili Liu, Wanjun Wang, Xiaoyue Li","doi":"10.2147/IDR.S633846","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the distribution and antimicrobial susceptibility of <i>Klebsiella pneumoniae</i> from Anqing First People's Hospital of Anhui Medical University from 2021 to 2025 and to provide rational regimens for clinical anti-infection.</p><p><strong>Methods: </strong>The non-repetitive bacterial strains were detected and collected in this hospital, Pathogen identification was performed using a mass spectrometer. Susceptibility testing was performed using an automated system or disk diffusion. The 2025 CLSI clinical standards were applied to determine susceptibility. Experimental susceptibility data were statistically analyzed using WHONET 5.6 software and SPSS26.0. Chi-square tests and trend tests were used for the statistical analyses.</p><p><strong>Results: </strong>8992 pathogenic strains were isolated during 2021-2025, including 1135 KPN, and the total detection rate was 12.6%. The annual detection rates from 2021 to 2025 were 12.8% (225/1,756), 11.7% (203/1,733), 14.5% (261/1,804), 12.6% (234/1,863), and 11.5% (212/1,836), respectively. The overall detection rate of Carbapenem-resistant <i>Klebsiella pneumoniae</i> (CRKP) was 13.8% (157/1135). Over the five-year period, the predominant specimen sources of the isolates were sputum (35.5%), midstream urine (27.8%), and secretions (17.3%). The top three departments by isolation rate were ICU, Neurosurgery, and Urology. The drug sensitivity results showed that the resistance of <i>K. pneumoniae</i> to most common antibiotics were different during 2021 to 2025 (<i>P</i> < 0.05), and it had certain resistance to common antibiotics. The resistance rate of <i>K. pneumoniae</i> to imipenem detected in the ICU was significantly higher than that in the neurosurgery and urology departments.</p><p><strong>Conclusion: </strong>During the five-year period from 2021 to 2025, the isolated <i>K. pneumoniae</i> showed varying levels of resistance to common antibacterial drugs in our hospital. The resistance rates varied among different departments. The situation of drug resistance remains severe. Therefore, The hospital must strengthen daily infection control measures and drug resistance monitoring to reduce the spread of drug-resistant bacteria.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"19 ","pages":"633846"},"PeriodicalIF":3.2000,"publicationDate":"2026-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13648167/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection and Drug Resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IDR.S633846","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To investigate the distribution and antimicrobial susceptibility of Klebsiella pneumoniae from Anqing First People's Hospital of Anhui Medical University from 2021 to 2025 and to provide rational regimens for clinical anti-infection.

Methods: The non-repetitive bacterial strains were detected and collected in this hospital, Pathogen identification was performed using a mass spectrometer. Susceptibility testing was performed using an automated system or disk diffusion. The 2025 CLSI clinical standards were applied to determine susceptibility. Experimental susceptibility data were statistically analyzed using WHONET 5.6 software and SPSS26.0. Chi-square tests and trend tests were used for the statistical analyses.

Results: 8992 pathogenic strains were isolated during 2021-2025, including 1135 KPN, and the total detection rate was 12.6%. The annual detection rates from 2021 to 2025 were 12.8% (225/1,756), 11.7% (203/1,733), 14.5% (261/1,804), 12.6% (234/1,863), and 11.5% (212/1,836), respectively. The overall detection rate of Carbapenem-resistant Klebsiella pneumoniae (CRKP) was 13.8% (157/1135). Over the five-year period, the predominant specimen sources of the isolates were sputum (35.5%), midstream urine (27.8%), and secretions (17.3%). The top three departments by isolation rate were ICU, Neurosurgery, and Urology. The drug sensitivity results showed that the resistance of K. pneumoniae to most common antibiotics were different during 2021 to 2025 (P < 0.05), and it had certain resistance to common antibiotics. The resistance rate of K. pneumoniae to imipenem detected in the ICU was significantly higher than that in the neurosurgery and urology departments.

Conclusion: During the five-year period from 2021 to 2025, the isolated K. pneumoniae showed varying levels of resistance to common antibacterial drugs in our hospital. The resistance rates varied among different departments. The situation of drug resistance remains severe. Therefore, The hospital must strengthen daily infection control measures and drug resistance monitoring to reduce the spread of drug-resistant bacteria.

2021-2025年中国某三级医院肺炎克雷伯菌临床分布特征及耐药趋势
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Infection and Drug Resistance
Infection and Drug Resistance Medicine-Pharmacology (medical)
CiteScore
5.60
自引率
7.70%
发文量
826
审稿时长
16 weeks
期刊介绍: About Journal Editors Peer Reviewers Articles Article Publishing Charges Aims and Scope Call For Papers ISSN: 1178-6973 Editor-in-Chief: Professor Suresh Antony An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书